ArticleJPRAS open2026
Novel approach to nipple reconstruction: First male FixNip prosthesis implantation.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and introduction: Nipple-areola complex (NAC) reconstruction remains a challenging aspect of breast reconstruction, particularly due to long-term loss of nipple projection and variability in aesthetic outcomes associated with traditional techniques. The FixNip nipple prosthesis is a novel implant-based device designed to provide stable projection and improved aesthetic results. We report the first documented clinical application of the FixNip prosthesis in a male patient following mastectomy. Case presentation: A 53-year-old male patient with a history of left-sided mastectomy for breast cancer underwent delayed NAC reconstruction using the FixNip prosthesis after prior autologous reconstruction with lipofilling. The prosthesis, composed of a nitinol framework enclosed within a silicone cap, was implanted through a small subcutaneous pocket under local anesthesia. Postoperative follow-up was performed at 1 week, 1 month, 6 months, and 12 months. Results: The procedure was completed without intraoperative or postoperative complications. At 6-month follow-up, the patient demonstrated stable nipple projection, satisfactory symmetry, and excellent aesthetic integration with the contralateral NAC. No signs of infection, implant displacement, skin necrosis, or adverse local reactions were observed. The patient reported high satisfaction with the aesthetic outcome and significant improvement in body image and quality of life. Discussion and conclusions: The FixNip prosthesis appears to be a safe and effective option for NAC reconstruction in selected patients, offering stable long-term projection with minimal surgical morbidity. This first reported application in a male patient highlights the potential role of implant-based NAC reconstruction in improving aesthetic and psychological outcomes following mastectomy. Further studies with larger patient cohorts and longer follow-up are needed to confirm long-term safety and efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.